FundedIQ
Biotechnology

ASLAN Pharmaceuticals: Funding, Investors & Team (Sep 2026)

ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in clinical-stage immunology and oncology-focused biopharmaceuticals.

aslanpharma.com LinkedIn Singapore, Singapore 11-50 employees
Biotechnology Health Care Medical Oncology Pharmaceutical
Total raised
$5.0M
Rounds
1
Latest
Undisclosed round
Mar 2024

ASLAN Pharmaceuticals has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Mar 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

ASLAN Pharmaceuticals Company Profile and Key Stats

Total funding raised
$5.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$5.0M in Mar 2024
Employees
11-50
reported band
Headquarters
Singapore, Singapore

Latest funding round on record: Mar 2024.

ASLAN Pharmaceuticals Funding Rounds

Date
Round
Amount
Undisclosed round
$5.0M

ASLAN Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
Carl Firth
Founder
Locked

Contact details for the ASLAN Pharmaceuticals team: 1 of 1 has an email address on file.

Start 14-day free trial →

ASLAN Pharmaceuticals Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
985
$5.0M

ASLAN Pharmaceuticals' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like ASLAN Pharmaceuticals in Biotechnology and Singapore

Companies Similar to ASLAN Pharmaceuticals

YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…

Seed $2.6M

Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…

Undisclosed round $4.6M

ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…

Undisclosed round

Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…

Series B $45.0M

Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…

Undisclosed round

Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…

Undisclosed round $40.0M

BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…

Pre-Seed $100k

Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…

Seed $4.0M

GDMC is a pharmaceutical organization that specializes in the production and development of genetic…

Series A $21.0M

Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…

Seed $3.8M

Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…

Undisclosed round $6.0M

Automera dedicates itself to the creation of innovative therapeutic approaches for drug development.

Series A $16.0M

ASLAN Pharmaceuticals Funding FAQs

What does ASLAN Pharmaceuticals do?

ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in clinical-stage immunology and oncology-focused biopharmaceuticals.

How much funding has ASLAN Pharmaceuticals raised?

ASLAN Pharmaceuticals has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Mar 2024.

When did ASLAN Pharmaceuticals last raise funding?

ASLAN Pharmaceuticals' most recent funding round on record is an undisclosed round of $5.0M, announced in Mar 2024.

Who founded ASLAN Pharmaceuticals?

FundedIQ lists Carl Firth (Founder) at ASLAN Pharmaceuticals.

Where is ASLAN Pharmaceuticals headquartered?

ASLAN Pharmaceuticals is based in Singapore, Central Region, Singapore.

How many employees does ASLAN Pharmaceuticals have?

ASLAN Pharmaceuticals is in the 11-50 employee band.

How does ASLAN Pharmaceuticals' funding compare to other Biotechnology startups?

ASLAN Pharmaceuticals' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's ASLAN Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ASLAN Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.